Treatment of neuromyelitis optica: Review and recommendations

Treatment of neuromyelitis optica: Review and recommendations

他のバージョン（1件）を表示する

Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Once regarded as a variant of multiple sclerosis (MS), NMO is now recognized to be a different disease with unique pathology and immunopathogenesis that does not respond to tr...

書誌詳細
主要な著者:	Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Isabel Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, De Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D, Guthy Jackson Charitable Foundation Clinical Consortium and Biorepository
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2012

類似資料

Treatment of Neuromyelitis Optica: Review and Recommendations.
著者:: Kimbrough, D, 等
出版事項: (2012)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
著者:: Jyh Yung Hor, 等
出版事項: (2020-06-01)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
著者:: Pittock, S, 等
出版事項: (2019)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
著者:: Fujihara, K, 等
出版事項: (2014)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
著者:: Collongues, N, 等
出版事項: (2013)

The borderland of neuromyelitis optica.
著者:: Matthews, L, 等
出版事項: (2009)

Neuromyelitis optica associated with systemic autoimmune diseases in children
著者:: Russo RA, 等
出版事項: (2008-09-01)

Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
著者:: Mealy, M, 等
出版事項: (2014)

Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis
著者:: Douglas Kazutoshi Sato, 等
出版事項: (2014-06-01)

Atypical presentations of neuromyelitis optica
著者:: Douglas Sato, 等
出版事項: (2011-10-01)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
著者:: Kim, W, 等
出版事項: (2012)

Use of mitoxantrone in neuromyelitis optica.
著者:: Kitley, J, 等
出版事項: (2011)

Current and future treatment approaches for neuromyelitis optica
著者:: Nicolas Collongues, 等
出版事項: (2011-03-01)

Treatment of neuromyelitis optica: an evidence based review
著者:: Douglas Sato, 等
出版事項: (2012-01-01)

Differential diagnosis of neuromyelitis optica spectrum disorders
著者:: Sung-Min Kim, 等
出版事項: (2017-07-01)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
著者:: Nour, M, 等
出版事項: (2014)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
著者:: Elsone, L, 等
出版事項: (2012)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
著者:: Waters, P, 等
出版事項: (2015)

Magnetic resonance imaging in neuromyelitis optica.
著者:: Tackley, G, 等
出版事項: (2014)

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
著者:: Nicolas Collongues, 等
出版事項: (2016-05-01)

Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort
著者:: Shervin Gholizadeh, 等
出版事項: (2024-10-01)

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
著者:: Cree, BAC, 等
出版事項: (2019)

A practical guide to the treatment of neuromyelitis optica.
著者:: Palace, J, 等
出版事項: (2012)

The evolving clinical spectrum of neuromyelitis optica
著者:: Viegas, S, 等
出版事項: (2008)

A mathematical model of cellular swelling in Neuromyelitis optica
著者:: Laranjeira, S, 等
出版事項: (2017)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
著者:: Sato, D, 等
出版事項: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
著者:: Matthews, L, 等
出版事項: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
著者:: Matthews, L, 等
出版事項: (2013)

Neuromyelitis Optica
著者:: Goyal V, 等
出版事項: (2009-10-01)

Neuromyelitis optica
著者:: Jacob Anu, 等
出版事項: (2007-01-01)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
著者:: Nour, M, 等
出版事項: (2015)

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.
著者:: Lucy Matthews, 等
出版事項: (2015-01-01)

Anti-aquaporin-4 antibodies in Devic’s neuromyelitis optica: therapeutic implications
著者:: Romain Marignier, 等
出版事項: (2010-09-01)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
著者:: Viegas, S, 等
出版事項: (2009)

Seasonal pattern of variation in neuromyelitis optica relapses
著者:: Elsone, L, 等
出版事項: (2012)

NMO-IgG in the diagnosis of neuromyelitis optica.
著者:: Jarius, S, 等
出版事項: (2007)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
著者:: Luppe, S, 等
出版事項: (2012)

Case Report: In Situ Expression of a Proliferation-Inducing Ligand in Neuromyelitis Optica
著者:: Laurie Baert, 等
出版事項: (2021-08-01)

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder
著者:: Achim Berthele, 等
出版事項: (2023-04-01)

Racial differences in neuromyelitis optica spectrum disorder
著者:: Kim, S, 等
出版事項: (2018)